Lista de obras - Vesna Blazevic - Dominio Público Uruguay

A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A–C subtypes and the ancestor sequence of the F–H subtypes. Preclinical and clinical studies

article

A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine

scientific article published on 27 August 2019

A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles

artículo científico publicado en 2012

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

artículo científico publicado en 2010

A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome

artículo científico publicado en 2004

A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome

Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses

artículo científico publicado en 2001

Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice

artículo científico publicado en 2016

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography

artículo científico publicado en 2012

Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus

artículo científico publicado en 2019

Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles ⬇️

artículo científico publicado el 18 de junio de 2013

Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays.

artículo científico publicado en 2014

Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses

article

Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.

artículo científico publicado en 2005

Development and maturation of norovirus antibodies in childhood

artículo científico publicado en 2015

Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.

artículo científico publicado en 2017

GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model.

artículo científico publicado en 2007

Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013.

artículo científico publicado en 2014

Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition

artículo científico publicado en 2015

Helper and Cytotoxic T Cell Responses of HIV Type 1-Infected Individuals to Synthetic Peptides of HIV Type 1 Rev

article

High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.

artículo científico publicado en 2014

Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: analysis of cellular immune responses

artículo científico publicado en 2001

His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display.

artículo científico publicado en 2015

Identification of a First Human Norovirus CD8 T Cell Epitope Restricted to HLA-A0201 Allele

Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.

artículo científico publicado en 2014

Immune-based approaches for control of HIV infection and viral-induced immunopathogenesis.

artículo científico publicado en 2000

Immunization with dendritic cells transfected in vivo with HIV-1 plasmid DNA induces HIV-1-specific immune responses

article

Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant

artículo científico publicado en 2019

Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection

artículo científico publicado en 2015

Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine

artículo científico publicado en 2006

Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects

artículo científico publicado en 2001

Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

artículo científico publicado en 2000

Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential

artículo científico publicado en 2018

Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens.

artículo científico publicado en 2017

Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.

artículo científico publicado en 2016

Multiple consecutive norovirus infections in the first 2 years of life

artículo científico publicado en 2015

Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children.

artículo científico publicado en 2011

Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera

scientific article published on 15 November 2018

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis

artículo científico publicado en 2011

Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007

artículo científico publicado en 2011

Norovirus vaccine: one step closer

artículo científico publicado en 2014

Norovirus-Specific Memory T Cell Responses in Adult Human Donors

artículo científico publicado en 2016

Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens

scientific article published on 19 September 2018

Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010.

artículo científico publicado en 2011

Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice. ⬇️

artículo científico publicado en 2018

Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype

artículo científico publicado en 2013

Prevalence of norovirus GII-4 antibodies in Finnish children

artículo científico publicado en 2011

Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue

artículo científico publicado en 2005

Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus

artículo científico publicado en 2011

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine

artículo científico publicado en 2015

Rapid and sensitive detection of norovirus antibodies in human serum with a biolayer interferometry biosensor

article published in 2015

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

artículo científico publicado en 2020

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles

artículo científico publicado en 2016

Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

artículo científico publicado en 2020

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine

artículo científico publicado en 2015

Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.

artículo científico publicado en 2017

Rotavirus vaccination and infection induce VP6-specific IgA responses

artículo científico publicado en 2016

Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins.

artículo científico publicado en 2016

Stable immobilisation of His-tagged proteins on BLI biosensor surface using cobalt

scholarly article by Sanna Auer et al published May 2017 in Sensors and Actuators B

T Cell Responses to Recall Antigens, Alloantigen, and Mitogen of HIV-Infected Patients Receiving Long-Term Combined Antiretroviral Therapy

article

Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice

artículo científico publicado en 2013

Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.

artículo científico publicado en 2016

Lista de obras de Vesna Blazevic

A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A–C subtypes and the ancestor sequence of the F–H subtypes. Preclinical and clinical studies

A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine

A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome

A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome

Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses

Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography

Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus

Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles ⬇️

Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays.

Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses

Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.

Development and maturation of norovirus antibodies in childhood

Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.

GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model.

Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013.

Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition

Helper and Cytotoxic T Cell Responses of HIV Type 1-Infected Individuals to Synthetic Peptides of HIV Type 1 Rev

High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.

Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: analysis of cellular immune responses

His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display.

Identification of a First Human Norovirus CD8 T Cell Epitope Restricted to HLA-A0201 Allele

Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.

Immune-based approaches for control of HIV infection and viral-induced immunopathogenesis.

Immunization with dendritic cells transfected in vivo with HIV-1 plasmid DNA induces HIV-1-specific immune responses

Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant

Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection

Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine

Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects

Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential

Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens.

Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.

Multiple consecutive norovirus infections in the first 2 years of life

Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children.

Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis

Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007

Norovirus vaccine: one step closer

Norovirus-Specific Memory T Cell Responses in Adult Human Donors

Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens

Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010.

Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice. ⬇️

Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype

Prevalence of norovirus GII-4 antibodies in Finnish children

Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue

Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine

Rapid and sensitive detection of norovirus antibodies in human serum with a biolayer interferometry biosensor

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles

Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine

Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.

Rotavirus vaccination and infection induce VP6-specific IgA responses

Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins.

Stable immobilisation of His-tagged proteins on BLI biosensor surface using cobalt

T Cell Responses to Recall Antigens, Alloantigen, and Mitogen of HIV-Infected Patients Receiving Long-Term Combined Antiretroviral Therapy

Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice

Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.

Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential